Navigation Links
Endologix to Present at 29th Annual J.P. Morgan Healthcare Conference
Date:1/4/2011

IRVINE, Calif., Jan. 4, 2011 /PRNewswire/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, is scheduled to present at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.Event:29th Annual J.P. Morgan Healthcare ConferenceDate:Wednesday, January 12, 2011Time:4:30 p.m. PTAn audio Web cast of the Company's presentation will be available by visiting the investor relations section of Endologix's Web site at www.endologix.com.  A replay of the presentation will be available for 30 days.

About Endologix, Inc.Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's flagship product is the Powerlink® System, which is an endovascular stent graft for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S. Additional information can be found on Endologix's Web site at www.endologix.com.  COMPANY CONTACT:

INVESTOR CONTACTS:Endologix, Inc.

The Ruth GroupJohn McDermott, CEO

Nick Laudico (646) 536-7030(949) 595-7200

Zack Kubow (646) 536-7020www.endologix.com
'/>"/>

SOURCE Endologix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Endologix Appoints Guido Neels to Its Board of Directors
2. Endologix Completes Acquisition of Nellix
3. Endologix to Host Physician Conference Call to Discuss Nellix Technology on November 11, 2010
4. Endologix Announces First Clinical Implant of Ventanaâ„¢ Stent Graft
5. Endologix to Acquire Nellix
6. Endologix Reports 30% Third Quarter 2010 Revenue Growth
7. Endologix to Present at Oppenheimer 21st Annual Healthcare Conference
8. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
9. Endologix to Report Third Quarter 2010 Financial Results on October 27, 2010
10. Endologix Receives CE Mark Approval for Expanded Line of Powerlink Products and PowerFit Aortic Extensions
11. Endologix Enters Development Agreement and Exclusive License for Balloon Expandable Stent Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... May 6, 2016 Appoints ... and its Application to Drug Development Including Development of ... , the life sciences consulting firm, today announced that ... an Associate Partner in its Cambridge, MA ... Miller, PhD, in the firm,s Medical Imaging consulting practice ...
(Date:5/5/2016)... 5, 2016 Endo International plc (NASDAQ: ... Douglas S. Ingram , former president of Allergan, Inc. and ... Sisitsky , managing partner of TPG Capital, to its Board ... "Endo recently embarked on a search ... expand the Board,s capabilities. Doug and Todd are experienced leaders, ...
(Date:5/5/2016)... Research and Markets has announced the addition of ...  report to their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Emission Tomography (PET) scanner and cyclotron install base in ... the current known number of PET scanners and cyclotrons ... also contains a detailed breakdown of this equipment by ...
Breaking Medicine Technology:
(Date:5/6/2016)... ... May 06, 2016 , ... Expert ... . , Since launching in September, 2014 Sleepopolis has resided at Sleepopolis-mattress-reviews.com ... now include pillows, sheets, mattress toppers, bed frames, and more. , Founder and ...
(Date:5/6/2016)... Utah (PRWEB) , ... May 06, 2016 , ... ... Step, an online provider of career-focused education and corporate training, and the National ... are pleased to announce Maritza Aquino as the second full-tuition scholarship recipient of ...
(Date:5/6/2016)... Washington, DC (PRWEB) , ... May 06, 2016 ... ... Blum, Executive Vice President at CareFirst Blue Cross BlueShield and Former Principal Deputy ... Officer at CareMore - an Anthem Company; Steve Ondra, MD, Chief Medical Officer ...
(Date:5/5/2016)... ... May 05, 2016 , ... Qrono Inc. , a ... development collaboration with the Australian critical medicine company, Phebra Pty Ltd. , ... LAI medicines can offer improved therapeutic benefits over oral formulations, including better bioavailability, ...
(Date:5/5/2016)... Tampa, FL (PRWEB) , ... May 05, 2016 ... ... hospital in Tampa to offer patients with non-valvular atrial fibrillation (A-Fib) an alternative ... (LAAC) Implant. Since first offering the procedure in April of 2015, Florida Hospital ...
Breaking Medicine News(10 mins):